Research Summary
Core needle biopsy devices are medical instruments used in diagnostic procedures to obtain tissue samples from suspicious or abnormal lesions in the body for further examination. The devices are designed to collect a core or cylindrical-shaped tissue sample, allowing for a more comprehensive analysis compared to fine-needle aspiration techniques. Core needle biopsy procedures are commonly performed to diagnose and characterize various conditions, including tumors, cysts, and other abnormalities in organs such as the breast, lung, liver, and prostate. The core needle biopsy devices typically consist of a hollow needle with a cutting edge and a spring-loaded mechanism that allows for controlled and precise tissue sampling. The collected tissue samples are then sent to a pathology laboratory for microscopic examination, which aids in accurate diagnosis and treatment planning for the patient. Core needle biopsy procedures are minimally invasive, offering a safer and less traumatic alternative to traditional surgical biopsies, and they play a crucial role in early detection and treatment of various medical conditions.
According to WENKH research statistics, the global Core Needle Biopsy Devices market sales revenue reached Million USD in 2024 and is expected to reach Million USD by 2032, with a compound annual growth rate (CAGR) of % from 2025 to 2032. Among them, the Asia-Pacific Core Needle Biopsy Devices market has experienced rapid changes in recent years, reaching Million USD in 2024, accounting for approximately % of the global market share. It is projected to reach Million USD by 2032.
The global Core Needle Biopsy Devices market is highly competitive, with key market players including Medtronic, Argon Medical Devices, BD, Boston Scientific, Cook Medical, C. R. Bard, Gallini Medical Devices, Hologic, Leica Biosystems, TSK Laboratory, Stryker, Zamar Care, etc. This report categorizes the competitive landscape of the global Core Needle Biopsy Devices market into three tiers based on annual revenue, with the top three market players holding approximately % of the total market share.
This report provides an in-depth analysis of the global Core Needle Biopsy Devices market, including market size, price trends, market status and future development prospects. It particularly focuses on the market share, product characteristics, pricing, revenue, sales volume and gross profit margin of major manufacturers in the global Core Needle Biopsy Devices industry. Additionally, this report provides an in-depth analysis of the market status and future development trends of different segments of Core Needle Biopsy Devices and their downstream application fields.
In terms of data coverage, this report includes extensive time-series data. Historical data spans from 2020 to 2024, providing a solid foundation for analyzing market development trends. The year 2025 is used as a base year to accurately assess the current market landscape, while forecast data extends from 2026 to 2032, using scientific analysis methods and models to offer forward-looking projections and insights into the market's future trajectory. This provides valuable reference information for industry participants and stakeholders.
The report covers regions and countries including North America, Europe, China, Asia Pacific (excluding China), Latin America, the Middle East, and Africa. It particularly focuses on the revenue and sales volume of Core Needle Biopsy Devices in these regions and countries, as well as the market share of key market players in each region. The report provides an in-depth analysis of the regional distribution and future development trends of the Core Needle Biopsy Devices market. By considering local policies, this report evaluates the market prospects of Core Needle Biopsy Devices in each region and country, aiming to help companies gain a comprehensive understanding of the industry characteristics and development potential in different regions, optimize regional business layout, and develop precise market strategies to achieve global development goals.
This report places significant emphasis on data quality and reliability, leveraging a wide range of data sources to ensure accuracy and validity. Primary data collection is conducted through multiple channels, including in-depth interviews with senior corporate executives, industry experts, supply chain participants, and end consumers. This helps to gain insights into corporate strategic planning, industry policies, supply chain dynamics, and user experiences. Secondary data sources cover an extensive range, including authoritative government statistics, customs databases, industry related reports, third-party paid databases, investment research reports, academic studies, corporate financial statements, real-time media updates, and information from international organizations, all of which serve as a solid foundation for data verification and analysis.
Companies Covered
Medtronic
Argon Medical Devices
BD
Boston Scientific
Cook Medical
C. R. Bard
Gallini Medical Devices
Hologic
Leica Biosystems
TSK Laboratory
Stryker
Zamar Care
Product Segment
Full-automatic Core Needle Biopsy Device
Semi-automatic Core Needle Biopsy Device
Product Application
Hospitals
Clinics
Others
Chapter Scope
Chapter 1: Product Statistical Scope, Product Segmentation Types and Downstream Applications, Overall Market Size, Current Status and Development Prospects
Chapter 2: Global Core Needle Biopsy Devices Industry Chain Analysis
Chapter 3: Global Core Needle Biopsy Devices Industry Environment Analysis and Porter's Five Forces Analysis
Chapter 4: Analysis of the Competitive Landscape of Major Companies in the Global Core Needle Biopsy Devices Market (Market Share, Product Revenue and Sales Volume Comparison, Tier Division, Corporate Expansion and M&A Trends)
Chapter 5: Analysis of Global Major Companies (Company Profiles, Product Features and Product Segment, Product Revenue, Product Sales Volume, Product Average Price, Product Gross Profit Margin and Geographical Sales Share)
Chapter 6: Global Core Needle Biopsy Devices Product Segment, Downstream Application and Major Regional Market Size Analysis (Sales Volume, Revenue and Average Price)
Chapter 7: North America Core Needle Biopsy Devices Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)
Chapter 8: Europe Core Needle Biopsy Devices Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)
Chapter 9: China Core Needle Biopsy Devices Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)
Chapter 10: Asia Pacific (excluding China) Core Needle Biopsy Devices Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)
Chapter 11: Latin America Core Needle Biopsy Devices Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)
Chapter 12: Middle East and Africa Core Needle Biopsy Devices Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)
Chapter 13: Research Conclusion
Chapter 14: Methodology and Data Source
Purpose and Value of the Report
Market Trend Insights: Analyze industry trends, market dynamics, and future growth potential to help companies forecast changes and develop strategic plans.
Competitive Landscape Analysis: Understand key players' revenue segmentation, strategies, market share, and business models to guide competitive decisions.
Investment Decision Support: Provide feasibility analysis through market size, growth rate, demand trends, and potential risks for informed investment decisions.
Target Customer and Demand Analysis: Examine consumer behavior, purchasing preferences, and pain points to optimize products and improve market penetration.
Policy and Regulatory Insights: Interpret relevant industry policies to ensure compliance and mitigate regulatory risks.
Business Model Optimization: Offer data-driven suggestions for enhancing business models and improving profitability.